Download PDF
Semin Thromb Hemost 2012; 38(08): 780-782
DOI: 10.1055/s-0032-1328889
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Cocaine-Levamisole Thrombotic Vasculopathy

Irene A. Dy
1   Department of Hematology and Oncology, St. Luke's Roosevelt Hospital Center, New York, New York
2   Continuum Cancer Centers of New York, New York, New York
,
Peter H. Wiernik
1   Department of Hematology and Oncology, St. Luke's Roosevelt Hospital Center, New York, New York
2   Continuum Cancer Centers of New York, New York, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
06 October 2012 (online)

    Permissions and Reprints

Abstract

The syndrome of cocaine-levamisole thrombotic vasculopathy is a tetrad of cutaneous manifestations, arthralgia, leukopenia, and positive antineutrophil cytoplasmic antigen (ANCA). Cocaine is cut with levamisole to potentiate its euphoric effects. However, along with this are the adverse reactions of levamisole such as fatal agranulocytosis, flu-like symptoms, and cutaneous thrombotic vasculopathy. High index of suspicion is needed for its diagnosis. This article will review on its toxicities, especially its prothrombotic effects.

Keywords

levamisole - cocaine - agranulocytosis - vasculitis - ANCA
 

  • References

  • 1 Finkel JB, Marhefka GD. Rethinking cocaine-associated chest pain and acute coronary syndromes. Mayo Clin Proc 2011; 86 (12) 1198-1207
    CrossrefPubMedGoogle Scholar
  • 2 Czuchlewski DR, Brackney M, Ewers C , et al. Clinicopathologic features of agranulocytosis in the setting of levamisole-tainted cocaine. Am J Clin Pathol 2010; 133 (3) 466-472
    CrossrefPubMedGoogle Scholar
  • 3 Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new cocaine adulterant. Clin Pharmacol Ther 2010; 88 (3) 408-411
    CrossrefPubMedGoogle Scholar
  • 4 Scheinfeld N, Rosenberg JD, Weinberg JM. Levamisole in dermatology: a review. Am J Clin Dermatol 2004; 5 (2) 97-104
    CrossrefPubMedGoogle Scholar
  • 5 Buchanan JA, Oyer RJ, Patel NR , et al. A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole. J Med Toxicol 2010; 6 (2) 160-164
    CrossrefPubMedGoogle Scholar
  • 6 Macfarlane DG, Bacon PA. Levamisole-induced vasculitis due to circulating immune complexes. BMJ 1978; 1 (6110) 407-408
    CrossrefPubMedGoogle Scholar
  • 7 Brackney M, Baumbach J, Ewers C , et al. Agranulocytosis associated with cocaine use - four States, March 2008-November 2009. MMWR Morb Mortal Wkly Rep 2009; 58 (49) 1381-1385
    PubMedGoogle Scholar
  • 8 Zhu NY, Legatt DF, Turner AR. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med 2009; 150 (4) 287-289
    CrossrefPubMedGoogle Scholar
  • 9 Poon SH, Baliog Jr CR, Sams RN, Robinson-Bostom L, Telang GH, Reginato AM. Syndrome of cocaine-levamisole-induced cutaneous vasculitis and immune-mediated leukopenia. Semin Arthritis Rheum 2011; 41 (3) 434-444
    CrossrefPubMedGoogle Scholar
  • 10 Walsh NMG, Green PJ, Burlingame RW, Pasternak S, Hanly JG. Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol 2010; 37 (12) 1212-1219
    CrossrefPubMedGoogle Scholar
  • 11 Raymon LP, Isenschmid DS. Letter to the editor: the possible role of levamisole in illicit cocaine preparations. J Anal Toxicol 2009; 33 (9) 620-622
    CrossrefPubMedGoogle Scholar
  • 12 Erkan D, Zhang HW, Shriky RC, Merrill JT. Dual antibody reactivity to beta2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome. Lupus 2002; 11 (4) 215-220
    CrossrefPubMedGoogle Scholar
  • 13 Wiens MO, Son WK, Ross C, Hayden M, Carleton B. Cases: Cocaine adulterant linked to neutropenia. CMAJ 2010; 182 (1) 57-59
    CrossrefPubMedGoogle Scholar
  • 14 Bradford M, Rosenberg B, Moreno J, Dumyati G. Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med 2010; 152 (11) 758-759
    CrossrefPubMedGoogle Scholar